Effect of gemfibrozil on the concentration and composition of serum lipoproteins A controlled study with special reference to initial triglyceride levels
- 1 February 1990
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 81 (1) , 11-17
- https://doi.org/10.1016/0021-9150(90)90054-m
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Treatment of type III hyperlipoproteinemia with gemfibrozil to retard progression of coronary artery diseasePublished by Elsevier ,2004
- High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease.Heart, 1988
- Serum lipoproteins in patients with myocardial infarctionAtherosclerosis, 1988
- Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart StudyJAMA, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Change in composition of high density lipoprotein during gemfibrozil therapyAtherosclerosis, 1987
- Particle size distribution of high density lipoproteins as a function of plasma triglyceride concentration in human subjectsAtherosclerosis, 1985
- Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in manPublished by American Medical Association (AMA) ,1984
- Cholesterol content of red blood cells and low-density lipoproteins in hypertriglyceridemiaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983
- Epidemiology as a Guide to Clinical DecisionsNew England Journal of Medicine, 1980